Selecting Medication for Depression: Do Genomics Matter? - Frankly Speaking Ep 304 - a podcast by Pri-Med

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-304

Overview: Pharmacogenomic testing has been suggested as a way to personalize medicine, particularly where the metabolism of medications can vary significantly. Unfortunately, despite increasing use of this testing, there has been little evidence showing a benefit in clinical outcomes. Listen to this podcast to explore the data on clinical outcomes for pharmacogenetic testing and how to best select medication for patients with depression.

Episode resource links:

• Oslin DW, Lynch KG, Shih MC, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022;328(2):151-161.

Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Further episodes of Frankly Speaking About Family Medicine

Further podcasts by Pri-Med

Website of Pri-Med